These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2022255)
1. Peroxisome proliferation in neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat. Rao MS; Thangada S; Subbarao V Exp Pathol; 1991; 41(1):44-9. PubMed ID: 2022255 [TBL] [Abstract][Full Text] [Related]
2. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats. Rao MS; Subbarao V; Reddy JK Cancer Lett; 1986 Jul; 32(1):33-9. PubMed ID: 3742486 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat. Goolsby CL; Rao MS Br J Cancer; 1996 Jan; 73(2):197-202. PubMed ID: 8546906 [TBL] [Abstract][Full Text] [Related]
4. Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator. Milano M; Reddy JK; Prasad JD; Rao MS Cancer Lett; 1987 Dec; 38(1-2):65-71. PubMed ID: 2891433 [TBL] [Abstract][Full Text] [Related]
5. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation. Rao MS; Subbarao V Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-induced hepatocarcinogenesis: levels of activating and detoxifying enzymes in hepatocellular carcinomas induced by ciprofibrate. Rao MS; Kokkinakis DM; Subbarao V; Reddy JK Carcinogenesis; 1987 Jan; 8(1):19-23. PubMed ID: 3100085 [TBL] [Abstract][Full Text] [Related]
7. Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound. Rao MS; Dwivedi RS; Subbarao V; Reddy JK Br J Cancer; 1988 Jul; 58(1):46-51. PubMed ID: 2901849 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of ciprofibrate-induced hepatocarcinogenesis in the rat by dimethylthiourea, a scavenger of hydroxyl radical. Rao MS; Subbarao V Oncol Rep; 1999; 6(6):1285-8. PubMed ID: 10523698 [TBL] [Abstract][Full Text] [Related]
9. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat. Graham MJ; Winham MA; Old SL; Gray TJ Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300 [TBL] [Abstract][Full Text] [Related]
10. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase. Rao MS; Tatematsu M; Subbarao V; Ito N; Reddy JK Cancer Res; 1986 Oct; 46(10):5287-90. PubMed ID: 2875789 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Yeldandi AV; Milano M; Subbarao V; Reddy JK; Rao MS Cancer Lett; 1989 Sep; 47(1-2):21-7. PubMed ID: 2636030 [TBL] [Abstract][Full Text] [Related]
12. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis. Glauert HP; Clark TD Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376 [TBL] [Abstract][Full Text] [Related]
13. Expression of peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase enzyme and its mRNA in peroxisome proliferator-induced liver tumors. Rao MS; Ide H; Yeldandi AV; Kumar S; Reddy JK Carcinogenesis; 1994 Nov; 15(11):2619-22. PubMed ID: 7955115 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferation and beta-oxidation in Fao and MH1C1 rat hepatoma cells, HepG2 human hepatoblastoma cells and cultured human hepatocytes: effect of ciprofibrate. Duclos S; Bride J; Ramirez LC; Bournot P Eur J Cell Biol; 1997 Apr; 72(4):314-23. PubMed ID: 9127731 [TBL] [Abstract][Full Text] [Related]
15. Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years. Graham MJ; Wilson SA; Winham MA; Spencer AJ; Rees JA; Old SL; Bonner FW Fundam Appl Toxicol; 1994 Jan; 22(1):58-64. PubMed ID: 8125214 [TBL] [Abstract][Full Text] [Related]
16. Different effects of the liver mitogens triiodo-thyronine and ciprofibrate on the development of rat hepatocellular carcinoma. Ledda-Columbano GM; Perra A; Concas D; Cossu C; Molotzu F; Sartori C; Shinozuka H; Columbano A Toxicol Pathol; 2003; 31(1):113-20. PubMed ID: 12597455 [TBL] [Abstract][Full Text] [Related]
17. Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator. Rao MS; Subbarao V Cancer Lett; 1995 Nov; 97(2):185-8. PubMed ID: 7497461 [TBL] [Abstract][Full Text] [Related]
18. Induction of peroxisome proliferation in hepatocytes transplanted into the anterior chamber of the eye. A model system for the evaluation of xenobiotic-induced effects. Rao MS; Thorgeirsson S; Reddy MK; Lalwani ND; Evarts RE; Usman MI; Singh B; Reddy JK Am J Pathol; 1986 Sep; 124(3):519-27. PubMed ID: 3532814 [TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-induced hepatocarcinogenesis: histochemical analysis of ciprofibrate-induced preneoplastic and neoplastic lesions for gamma-glutamyl transpeptidase activity. Rao MS; Subbarao V; Reddy JK J Natl Cancer Inst; 1986 Oct; 77(4):951-6. PubMed ID: 2876121 [TBL] [Abstract][Full Text] [Related]
20. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator. Awasthi YC; Singh SV; Goel SK; Reddy JK Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]